Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Allogeneic Hematopoietic Stem Cell Transplantation × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 3 Wilms Tumor 1 TP53 1 Primary Malignant Neoplasm of Ovary 1 Older Patients 1 Hodgkin Disease 1 GATA2 Deficiency 1 Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Decitabine 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown

Allogeneic Hematopoietic Stem Cell Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡